Angiodynamics to report fiscal 2022 fourth quarter and full-year financial results on july 12, 2022

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that it will report financial results for the fourth quarter and fiscal year 2022 before the market open on tuesday, july 12, 2022. the company's management will host a conference call at 8:00 a.m. et the same
ANGO Ratings Summary
ANGO Quant Ranking